Recent News

429 News Items found
MSK scientists Margaret Callahan, Ronglai Shen, and Katherine Panageas
MSK Study Identifies Biomarker That May Help Predict Benefits of Immunotherapy
A blood-based test identifies patients in whom immunotherapy may ‘LAG.’
In the Lab
Scientist Gabriela Chiosis in her lab
Experimental Drug Targets Misbehaving Proteins in Brain Cancer and Alzheimer’s Disease
Memorial Sloan Kettering researchers are studying how drugs that reverse malfunctioning proteins may treat disease.
Memorial Sloan Kettering surgeon Prasad Adusumilli
CAR T Cell Therapy Shows Promise for Treating Mesothelioma
A combination immunotherapy approach using CAR T cells could be an effective new way to treat mesothelioma.
MSK radiologist Andreas Wibmer
Brown Fat — Which Warms Babies and Bears — Protects Against Harmful Aspects of Obesity, Study Finds
People with small amounts of brown fat have lower risk of certain obesity-related conditions, according to a retrospective study conducted by researchers at Memorial Sloan Kettering.
Memorial Sloan Kettering immunologist Frederic Geissmann
Feel the Burn: Researchers Identify Fat Storage Protein That Could Be Key to Alleviating Obesity
Researchers discover how immune cells called macrophages regulate whether fat is stored or burned.
MSK cancer biologist Triparna Sen
MSK Scientists Reveal Biology of Shape-Shifting Lung Cancer
Lung cancer has an uncanny ability to change its identity to resist drugs. Researchers are learning what drives these changes.
Group photo of researchers Michael Berger, Marc Ladanyi, Dana Tsui, Rose Brannon, Ryma Benayed, Ahmet Zehir, and David Klimstra.
How a Cutting-Edge Liquid Biopsy for Cancer Was Created at MSK
MSK-ACCESS, a blood test that can detect mutations in 129 genes related to cancer, has already helped guide the treatment of more than 2,800 patients at MSK.
In the Lab
Physician-scientist Omar Abdel-Wahab
Research Suggests How Boosting Neoantigens Can Make Immunotherapy More Effective
In mice, drugs that change the way proteins are assembled appear to make checkpoint inhibitor drugs work better.
MSK computational biologist Sohrab Shah
Scientists Obtain Real-Time Look at How Cancers Evolve
With the help of machine learning, computational biologists are learning to predict how cancers will evolve.
Zsofia Stadler
Knowledge of Inherited Gene Mutations Increasingly Can Guide Cancer Treatment
An analysis of patients who received molecular testing at MSK has found that about half of those with hereditary gene mutations could benefit from treatment with therapies that target those alterations.